Primecap Management CO Charles River Laboratories International, Inc. Transaction History

Primecap Management CO

  • $134 Billion
  • Q3 2024

A detailed history of Primecap Management CO transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Primecap Management CO holds 273,620 shares of CRL stock, worth $60.4 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
273,620
Previous 273,730 0.04%
Holding current value
$60.4 Million
Previous $56.5 Million 4.68%
% of portfolio
0.04%
Previous 0.04%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024
SELL
$187.96 - $245.29 $20,675 - $26,981
-110 Reduced 0.04%
273,620 $53.9 Million
Q2 2024

Aug 09, 2024
SELL
$206.39 - $268.73 $41,278 - $53,746
-200 Reduced 0.07%
273,730 $56.5 Million
Q3 2023

Nov 13, 2023
SELL
$194.44 - $217.61 $9,722 - $10,880
-50 Reduced 0.02%
273,930 $53.7 Million
Q1 2023

May 15, 2023
SELL
$191.89 - $259.92 $2.06 Million - $2.8 Million
-10,760 Reduced 3.78%
273,980 $55.3 Million
Q4 2022

Feb 13, 2023
SELL
$197.11 - $250.07 $1.99 Million - $2.52 Million
-10,080 Reduced 3.42%
284,740 $62 Million
Q3 2022

Nov 14, 2022
SELL
$182.44 - $250.54 $189,737 - $260,561
-1,040 Reduced 0.35%
294,820 $58 Million
Q2 2022

Aug 11, 2022
SELL
$204.13 - $302.4 $5.93 Million - $8.78 Million
-29,030 Reduced 8.94%
295,860 $63.3 Million
Q1 2022

May 11, 2022
SELL
$255.51 - $362.11 $8.4 Million - $11.9 Million
-32,890 Reduced 9.19%
324,890 $92.3 Million
Q4 2021

Feb 11, 2022
SELL
$351.38 - $448.68 $2.47 Million - $3.16 Million
-7,040 Reduced 1.93%
357,780 $135 Million
Q3 2021

Nov 12, 2021
SELL
$372.64 - $458.3 $257,121 - $316,227
-690 Reduced 0.19%
364,820 $151 Million
Q2 2021

Aug 10, 2021
SELL
$294.17 - $371.65 $1.4 Million - $1.77 Million
-4,750 Reduced 1.28%
365,510 $135 Million
Q1 2021

May 14, 2021
SELL
$249.67 - $299.48 $42,443 - $50,911
-170 Reduced 0.05%
370,260 $107 Million
Q4 2020

Feb 08, 2021
SELL
$222.0 - $252.62 $237,540 - $270,303
-1,070 Reduced 0.29%
370,430 $92.6 Million
Q3 2020

Nov 13, 2020
SELL
$175.56 - $226.45 $895,356 - $1.15 Million
-5,100 Reduced 1.35%
371,500 $84.1 Million
Q2 2020

Aug 13, 2020
SELL
$118.84 - $189.72 $178,260 - $284,580
-1,500 Reduced 0.4%
376,600 $65.7 Million
Q1 2020

May 14, 2020
SELL
$98.9 - $178.34 $405,490 - $731,194
-4,100 Reduced 1.07%
378,100 $47.7 Million
Q4 2019

Feb 14, 2020
SELL
$126.05 - $152.76 $176,470 - $213,864
-1,400 Reduced 0.36%
382,200 $58.4 Million
Q3 2019

Nov 13, 2019
SELL
$125.07 - $143.67 $1.43 Million - $1.64 Million
-11,400 Reduced 2.89%
383,600 $50.8 Million
Q2 2019

Aug 14, 2019
SELL
$123.4 - $148.55 $1.11 Million - $1.34 Million
-9,000 Reduced 2.23%
395,000 $56.1 Million
Q1 2019

May 14, 2019
SELL
$104.82 - $146.73 $10,482 - $14,672
-100 Reduced 0.02%
404,000 $58.7 Million
Q4 2018

Feb 12, 2019
SELL
$105.09 - $137.23 $1.79 Million - $2.33 Million
-17,000 Reduced 4.04%
404,100 $45.7 Million
Q3 2018

Nov 13, 2018
SELL
$112.11 - $134.54 $336,330 - $403,620
-3,000 Reduced 0.71%
421,100 $56.7 Million
Q2 2018

Aug 13, 2018
SELL
$102.37 - $117.25 $20,474 - $23,450
-200 Reduced 0.05%
424,100 $47.6 Million
Q1 2018

May 14, 2018
SELL
$98.19 - $115.2 $157,104 - $184,320
-1,600 Reduced 0.38%
424,300 $45.3 Million
Q4 2017

Feb 13, 2018
SELL
$100.43 - $118.09 $30,129 - $35,427
-300 Reduced 0.07%
425,900 $46.6 Million
Q3 2017

Nov 13, 2017
BUY
$96.72 - $109.26 $41.2 Million - $46.6 Million
426,200
426,200 $46 Million

Others Institutions Holding CRL

# of Institutions
714
Shares Held
51.5M
Call Options Held
233K
Put Options Held
236K
View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

CRL Quotes by TradingView
  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $11.2B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Primecap Management CO Portfolio

Follow Primecap Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Primecap Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Primecap Management CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email